Aarkstore - Healthcare Market Access Morocco

1
Healthcare Market Access Morocco
Morocco has inadequate numbers of physicians
(0.5 per 1,000 people) and hospital beds (1.0 per
1,000 people) and poor access to water (82
percent of the population) and sanitation (75
percent of the population). The health care
system includes 122 hospitals, 2,400 health
centers, and 4 university clinics, but they are
poorly maintained and lack adequate capacity to
meet the demand for medical care. Only 24,000
beds are available for 6 million patients seeking
care each year, including 3 million emergency
cases. The health budget corresponds to 1.1
percent of gross domestic product and 5.5 ercent
of the central government budget
2
Summary

• Country Landscape The section details about
  the geographical details of Morocco. It also
  details the prevalent economic conditions of
  Morocco in terms of GDP per capita, GDP sources,
  demographic profile of the country, and political
  structure and environment.
• Healthcare infrastructure The section provides
  data on the current health and hygiene status of
  the citizens based parameters such as sanitation
  and safe drinking water access, HIV/AIDS
  prevalence, contraceptive usage, maternal and
  infant mortality, hospital bed and physician
  density etc. The sections also give detailed
  account of general healthcare structure of the
  country in terms of primary, secondary and
  tertiary care, and also a general note on the
  countrys health expenditure.
• Pharmaceutical Market Access The sections gives
  detailed account of various types of health
  insurance currently operating in Morocco, their
  coverage in terms of health risks and benefits
  and also in terms of population coverage. The
  section gives detailed account of health
  insurance for public sector and private sector
  employees. The section also compares the
  efficiencies of various African medical
  regulatory agencies and their approval approach
  for a MNC pharmaceutical company. More
  specifically, the section deals with the
  regulatory agency and the new drug and
  reimbursement approval in Morocco.

3
Why should you buy this report

• As every countrys market access landscape is
  unique and evolving, it makes a prudent decision
  to have a country specific market access
  strategy. Moreover, the success of any
  pharmaceutical company hinges on successfully
  navigating challenges posed by the various
  stakeholders and regulatory bodies for effective
  product commercialization. This report will
  serve as a handy tool for pharmaceutical and
  other related healthcare stakeholders to
  Understand the macro and micro parameters that
  will play a pivotal role in making business
  decisions Identify, target and collaborate with
  the relevant stakeholders that hold key to
  effective product commercialization
  Conceptualize and formulate plausible market
  access strategies based on the insights generated
  Identify and foresee the major trends and
  policies likely to impact the regulatory, pricing
  and reimbursement landscape of the country
  Capitalize on the opportunities presented by the
  countrys pharmaceutical market and mitigate the
  challenges posed by the competitors and
  stakeholders/regulatory bodies Generate market
  specific insights that are actionable and
  commercially viable
• Leverage market access insights by
  incorporating physicians and payer priorities so
  as to develop effective sales and marketing
  strategies resulting in increased brand and
  company revenue Correctly ascertain the
  appropriate market access levers and barriers
  that will drive or hamper the brand performance
  Prioritize and assign optimal resources required
  for implementation of various market access
  activities

4
Table of Content

• EXECUTIVE SUMMARY 6
• 2 COUNTRY LANDSCAPE 8
• 2.1 Geography 8
• 2.2 Economic environment 9
• HEALTHCARE INFRASTRUCTURE 15
• 3.1.1 Healthcare system 17
• MARKET ACCESS 21
• 4.1 Health insurance system 21
• 4.1.1 AMO Mandatory health insurance (Assurance
  Maladie Obligatoire) 22
• 4.1.2 RAMED Medical assistance scheme (Régime
  dAssistance Médicale) 25
• 5 CONCLUSION 34
• 6 APPENDIX 35
• 6.1 Glossary 35
• 6.2 Coverage rates for long-term and costly
  conditions 37
• 6.3 Essential drug list of Morocco 41
• 6.4 Reimbursement of anti-cancer drugs (in MAD)
  73

5
List of Tables

• Table 1 GDP Real growth rate of Morocco 8Table
  2 GDP composition (2012 estimates) by sector of
  origin 8Table 3 Demographic breakdown of
  Morocco based on 2014 estimates 11Table 4 Major
  urban cities and their population based on 2011
  estimates 11Table 5 Educational parameters
  12Table 6 Access to safe drinking water and
  sanitation 14Table 7 Healthcare indicators of
  Morocco 16Table 8 Breakdown of healthcare
  delivery in public and private sectors 17Table
  9 Breakdown of income and major expenditure of
  CNSS and CNOPS for 2012 24Table 10 Breakdown of
  income and major expenditure of RAMED for 2012
  25Table 11 Coverage rates for long-term and
  costly conditions 36Table 12 Coverage rate of
  lasting and costly disorders 39Table 13
  Essential drug list of Morocco 40Table 14
  Reimbursements of anti-cancer drugs 72

6
List of Figures

• Figure 1 Changing trends of demographics of
  Morocco 10Figure 2 Breakdown share of hospital
  beds (A) in public and private hospitals
  18Figure 3 Health care professionals (B) in
  public and private hospitals 18Figure 4
  Financing of total health expenditure in Morocco
  19Figure 5 Intended coverage of population by
  insurance scheme 20Figure 6 Share of AMO
  coverage by insurance provider 21Figure 7 CNSS
  pay-outs for short-term, long-term, and family
  care (A) 23Figure 8 CNSS beneficiaries
  receiving short-term, long-term, and family care
  (B) 23Figure 9 Drug approval and reimbursement
  process in Morocco 32

Browse full report Or Sample Request
_at_ http//www.aarkstore.com/pharmaceuticals-healthc
are/117429/healthcare-market-access-morocco
7
Related Reports

• Global Raman Spectroscopy Industry 2015 Market
  Research Report
• Global Contraceptives Industry Report 2015
• Prescription Drugs Industry Forecasts - China
  Focus
• Cardiovascular Devices Industry Forecasts - China
  Focus
• Emerging Pharmaceuticals Industry Forecasts -
  China Focus

8
Follow Us
https//www.facebook.com/aarkstoredotcom
https//twitter.com/aarkstore
https//plus.google.com/Aarkstoredotcom/posts
https//www.linkedin.com/company/aarkstore-enterpr
ise
9
Office Address Office No. - 809, 8th
Floor,B-Wing, Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Mail us at
contact_at_aarkstore.com 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756
4953